All Featured Insights

Solo living is becoming much more common in American society. As the concept of the American family shifts, and in this case, unwinds, healthcare leaders need to be attuned to new demands—and nimble enough to meet them.

The FTC finalizes its premerger notification rule, Walgreens announces over 1K closures, and providers win a large antitrust class action settlement.

Some health systems may find themselves wondering if the retreat of both Walmart and Walgreens proves that primary care delivery is just too hard for disruptors to find success.

FTC sues PBMs over insulin pricing, a House bill would extend telehealth flexibilities, and HRSA awards contracts for the new organ transplant system.

We’re pleased to welcome you to our Strategy Spotlight blog, a space where we intend to regularly share our insights—and those of our colleagues—on the evolving challenges and opportunities healthcare organizations are confronting.

As healthcare market conditions continue to stabilize after several years of pandemic-era volatility, many hospital and health system leaders are revisiting their organizations’ strategic options for long-term sustainability.

The new generation of weight-loss drugs has the potential to help reduce prevalence of obesity and Type 2 diabetes, two of the most prevalent chronic conditions. How might that affect hospital operations and capital and financial planning?

After several years of grappling with one existential challenge after another, many organizations may find the task of resetting their strategy overwhelming. In our experience, most health systems have not asked or answered the difficult questions required to chart a new path.

Following the US Senate Finance Committee’s recent white paper on Medicare physician payment reform, the graphic shows how Medicare payments to physicians have not kept pace with inflation.

Ozempic trial shows the drug slows kidney disease progression, a blood-based colorectal cancer test is endorsed for FDA approval, and nursing home trade groups sue over the new staffing mandate.

In recent years, the Medicare Advantage (MA) program enjoyed both rapid membership growth and positive attention from healthcare organizations and advocates. As of the beginning of 2024, 33.4 million Americans were enrolled in MA, up 7% from 2023.

Walmart’s failure as a healthcare provider points to some big problems in U.S. healthcare, including a difficult business model, an unfriendly reimbursement model, and a basic healthcare expense-to-revenue problem.